Follow
Robert J Fox
Robert J Fox
Mellen Center for Multiple Sclerosis, Cleveland Clinic
Verified email at ccf.org - Homepage
Title
Cited by
Cited by
Year
Defining the clinical course of multiple sclerosis
FD Lublin, SC Reingold, JA Cohen, GR Cutter, PS Sørensen, ...
Neurology 83 (3), 278-286, 2014
8154*2014
B-cell depletion with rituximab in relapsing–remitting multiple sclerosis
SL Hauser, E Waubant, DL Arnold, T Vollmer, J Antel, RJ Fox, A Bar-Or, ...
New England Journal of Medicine 358 (7), 676-688, 2008
27522008
Placebo-controlled phase 3 study of oral BG-12 or glatiramer in multiple sclerosis
RJ Fox, DH Miller, JT Phillips, M Hutchinson, E Havrdova, M Kita, M Yang, ...
New England Journal of Medicine 367 (12), 1087-1097, 2012
15762012
Mitochondrial dysfunction as a cause of axonal degeneration in multiple sclerosis patients
R Dutta, J McDonough, X Yin, J Peterson, A Chang, T Torres, T Gudz, ...
Annals of neurology 59 (3), 478-489, 2006
9692006
Siponimod versus placebo in secondary progressive multiple sclerosis (EXPAND): a double-blind, randomised, phase 3 study
L Kappos, A Bar-Or, BAC Cree, RJ Fox, G Giovannoni, R Gold, ...
The Lancet 391 (10127), 1263-1273, 2018
9682018
Rituximab in relapsing‐remitting multiple sclerosis: a 72‐week, open‐label, phase I trial
A Bar‐Or, PAJ Calabresi, D Arnold, C Markowitz, S Shafer, LH Kasper, ...
Annals of neurology 63 (3), 395-400, 2008
6032008
Treatment of neuromyelitis optica with rituximab
A Jacob, BG Weinshenker, I Violich, N McLinskey, L Krupp, RJ Fox, ...
Arch Neurol 65 (11), 1443-8, 2008
5452008
Long-term antidepressant administration alters corticotropin-releasing hormone, tyrosine hydroxylase, and mineralocorticoid receptor gene expression in rat brain. Therapeutic …
LS Brady, HJ Whitfield, RJ Fox, PW Gold, M Herkenham
The Journal of clinical investigation 87 (3), 831-837, 1991
4231991
Demyelination causes synaptic alterations in hippocampi from multiple sclerosis patients
R Dutta, A Chang, MK Doud, GJ Kidd, MV Ribaudo, EA Young, RJ Fox, ...
Annals of neurology 69 (3), 445-454, 2011
3582011
MRI findings in Susac’s syndrome
JO Susac, FR Murtagh, RA Egan, JR Berger, R Bakshi, N Lincoff, ...
Neurology 61 (12), 1783-1787, 2003
3502003
Progressive multiple sclerosis: prospects for disease therapy, repair, and restoration of function
D Ontaneda, AJ Thompson, RJ Fox, JA Cohen
The Lancet 389 (10076), 1357-1366, 2017
3462017
Multiple sclerosis normal‐appearing white matter: Pathology–imaging correlations
NM Moll, AM Rietsch, S Thomas, AJ Ransohoff, JC Lee, R Fox, A Chang, ...
Annals of neurology 70 (5), 764-773, 2011
3362011
Effect of plasma exchange in accelerating natalizumab clearance and restoring leukocyte function
BO Khatri, S Man, G Giovannoni, AP Koo, JC Lee, B Tucky, F Lynn, ...
Neurology 72 (5), 402-409, 2009
3192009
Outcomes and risk factors associated with SARS-CoV-2 infection in a North American registry of patients with multiple sclerosis
A Salter, RJ Fox, SD Newsome, J Halper, DKB Li, P Kanellis, K Costello, ...
JAMA neurology 78 (6), 699-708, 2021
2772021
Phase 2 trial of ibudilast in progressive multiple sclerosis
RJ Fox, CS Coffey, R Conwit, ME Cudkowicz, T Gleason, A Goodman, ...
New England Journal of Medicine 379 (9), 846-855, 2018
2742018
Inferior Clinical Outcome of the CD4+ Cell Count–Guided Antiretroviral Treatment Interruption Strategy in the SMART Study: Role of CD4+ Cell Counts and HIV …
Strategies for Management of Antiretroviral Therapy (SMART) Study Group
The Journal of infectious diseases 197 (8), 1145-1155, 2008
2592008
Clinical trials in progressive multiple sclerosis: lessons learned and future perspectives
D Ontaneda, RJ Fox, J Chataway
The Lancet Neurology 14 (2), 208-223, 2015
2572015
Modulating CCR2 and CCL2 at the blood–brain barrier: relevance for multiple sclerosis pathogenesis
D Mahad, MK Callahan, KA Williams, EE Ubogu, P Kivisäkk, B Tucky, ...
Brain 129 (1), 212-223, 2006
2442006
Cortical remyelination: a new target for repair therapies in multiple sclerosis
A Chang, SM Staugaitis, R Dutta, CE Batt, KE Easley, AM Chomyk, ...
Annals of neurology 72 (6), 918-926, 2012
2262012
Associations of disease-modifying therapies with COVID-19 severity in multiple sclerosis
S Simpson-Yap, E De Brouwer, T Kalincik, N Rijke, JA Hillert, C Walton, ...
Neurology 97 (19), e1870-e1885, 2021
2242021
The system can't perform the operation now. Try again later.
Articles 1–20